Integrated BioPharma, Inc. (INBP)
0.1825
-0.01
(-3.44%)
USD |
OTCM |
Oct 12, 16:00
Integrated BioPharma Cash from Investing (Quarterly) : -0.149M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.149M |
| March 31, 2026 | 0.006M |
| December 31, 2025 | -0.024M |
| September 30, 2025 | -0.173M |
| June 30, 2025 | -0.004M |
| March 31, 2025 | -0.116M |
| December 31, 2024 | -0.029M |
| September 30, 2024 | -0.056M |
| June 30, 2024 | -0.146M |
| March 31, 2024 | -0.345M |
| December 31, 2023 | -0.024M |
| September 30, 2023 | -0.038M |
| June 30, 2023 | -0.017M |
| March 31, 2023 | -0.016M |
| December 31, 2022 | -0.028M |
| September 30, 2022 | -0.05M |
| June 30, 2022 | -0.035M |
| March 31, 2022 | -0.143M |
| December 31, 2021 | -0.156M |
| September 30, 2021 | -0.131M |
| June 30, 2021 | -0.145M |
| March 31, 2021 | -0.033M |
| December 31, 2020 | -0.064M |
| September 30, 2020 | 0.043M |
| June 30, 2020 | -0.04M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.028M |
| December 31, 2019 | -0.04M |
| September 30, 2019 | -0.058M |
| June 30, 2019 | -0.064M |
| March 31, 2019 | -0.064M |
| December 31, 2018 | -0.268M |
| September 30, 2018 | -0.026M |
| June 30, 2018 | -0.032M |
| March 31, 2018 | -0.004M |
| December 31, 2017 | -0.099M |
| September 30, 2017 | -0.107M |
| June 30, 2017 | -0.017M |
| March 31, 2017 | -0.227M |
| December 31, 2016 | -0.042M |
| September 30, 2016 | -0.041M |
| June 30, 2016 | -0.069M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.003M |
| September 30, 2015 | -0.041M |
| June 30, 2015 | 0.071M |
| March 31, 2015 | -0.039M |
| December 31, 2014 | -0.02M |
| September 30, 2014 | -0.168M |
| June 30, 2014 | -0.067M |
| March 31, 2014 | -0.086M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Medifast, Inc. | -1.233M |
| BioForce Nanosciences Holdings, Inc. | 0.00 |
| Skinvisible, Inc. | 0.00 |
| SkyTech Orion Global Corp. | 0.00 |
| Nevis Brands, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.194M |
| Cash from Financing (Quarterly) | -0.012M |
| Free Cash Flow | 0.895M |
| Free Cash Flow Per Share (Quarterly) | -0.0432 |
| Free Cash Flow to Equity (Quarterly) | -1.075M |
| Free Cash Flow to Firm (Quarterly) | -1.343M |
| Free Cash Flow Yield | 15.74% |